Arginine

Arginine

SCHEMBL4820161

CCOC(Cc1ccc(NCCCCC(=O)N2CCOc3ccccc32)cc1)C(=O)O.N=C(N)NCCCC(N)C(=O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACES1PR1S1PR4S1PR5

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.42
PPARG P37231 7/20 0.41
PPARA Q07869 5/20 0.41
GAA P10253 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 4/20 0.37
RXFP1 Q9HBX9 3/20 0.37
LMNA P02545 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TP53 P04637 2/20 0.36
PTPRF P10586 1/20 0.35
PTPN2 P17706 1/20 0.35
PTPN1 P18031 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL4820167 1.00 RAB9A (0.42) RAB9APPARGPPARAGAAL3MBTL1
SCHEMBL4820171 0.91 RAB9A (0.40) RAB9APPARGPPARAGAAL3MBTL1
SCHEMBL1865225 0.89 PPARG (0.50) RAB9APPARGPPARAGAAL3MBTL1
Arginine SCHEMBL4826312 0.89 PPARG (0.44) PPARGPPARA
Arginine SCHEMBL4826319 0.89 PPARG (0.44) PPARGPPARA
Arginine SCHEMBL4824341 0.88 PPARG (0.45) PPARGPPARAMAPTRXFP1LMNA
Arginine SCHEMBL4824344 0.88 PPARG (0.45) PPARGPPARAMAPTRXFP1LMNA
SCHEMBL1867257 0.82 MAPT (0.46) RAB9APPARGPPARAGAAL3MBTL1
Arginine SCHEMBL4824934 0.81 PPARG (0.40) RAB9APPARGPPARA
Arginine SCHEMBL4824931 0.81 PPARG (0.40) RAB9APPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365064-B2 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2008-04-29 US disclosed
US-20050113368-A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113368-A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them CYP3A5, HBZ, CYP4Z1 RAB9A 3400/4885PPARG 86/4885PPARA 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.